NYSE:BAX - US0718131099 - Common Stock
The current stock price of BAX is 24.69 USD. In the past month the price increased by 12.43%. In the past year, price decreased by -34.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.07 | 230.89B | ||
ISRG | INTUITIVE SURGICAL INC | 58.79 | 169.67B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.28 | 156.32B | ||
SYK | STRYKER CORP | 30.46 | 149.64B | ||
MDT | MEDTRONIC PLC | 16.78 | 119.05B | ||
BDX | BECTON DICKINSON AND CO | 13.52 | 55.31B | ||
IDXX | IDEXX LABORATORIES INC | 53.88 | 51.77B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.65 | 47.75B | ||
RMD | RESMED INC | 28.74 | 40.19B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.82 | 33.66B | ||
DXCM | DEXCOM INC | 44.32 | 29.55B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.42 | 26.56B |
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 38,000 full-time employees. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. The company provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
BAXTER INTERNATIONAL INC
One Baxter Parkway
Deerfield ILLINOIS 60015 US
CEO: Jose E. Almeida
Employees: 38000
Phone: 12249482000
The current stock price of BAX is 24.69 USD. The price increased by 1.19% in the last trading session.
The exchange symbol of BAXTER INTERNATIONAL INC is BAX and it is listed on the New York Stock Exchange, Inc. exchange.
BAX stock is listed on the New York Stock Exchange, Inc. exchange.
22 analysts have analysed BAX and the average price target is 29.98 USD. This implies a price increase of 21.42% is expected in the next year compared to the current price of 24.69. Check the BAXTER INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BAXTER INTERNATIONAL INC (BAX) has a market capitalization of 12.68B USD. This makes BAX a Large Cap stock.
BAXTER INTERNATIONAL INC (BAX) currently has 38000 employees.
BAXTER INTERNATIONAL INC (BAX) has a resistance level at 24.7. Check the full technical report for a detailed analysis of BAX support and resistance levels.
The Revenue of BAXTER INTERNATIONAL INC (BAX) is expected to grow by 7.11% in the next year. Check the estimates tab for more information on the BAX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BAXTER INTERNATIONAL INC (BAX) has a dividend yield of 2.79%. The yearly dividend amount is currently 1.16. Check the full fundamental report for a detailed analysis of BAX dividend history, reliability and sustainability.
BAXTER INTERNATIONAL INC (BAX) will report earnings on 2025-11-06, before the market open.
The PE ratio for BAXTER INTERNATIONAL INC (BAX) is 9.8. This is based on the reported non-GAAP earnings per share of 2.52 and the current share price of 24.69 USD. Check the full fundamental report for a full analysis of the valuation metrics for BAX.
The outstanding short interest for BAXTER INTERNATIONAL INC (BAX) is 3.74% of its float. Check the ownership tab for more information on the BAX short interest.
ChartMill assigns a technical rating of 1 / 10 to BAX. When comparing the yearly performance of all stocks, BAX is a bad performer in the overall market: 92.17% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to BAX. BAX has an average financial health and profitability rating.
Over the last trailing twelve months BAX reported a non-GAAP Earnings per Share(EPS) of 2.52. The EPS decreased by -12.8% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.74% | ||
ROE | -2.12% | ||
Debt/Equity | 1.3 |
22 analysts have analysed BAX and the average price target is 29.98 USD. This implies a price increase of 21.42% is expected in the next year compared to the current price of 24.69.
For the next year, analysts expect an EPS growth of -9.02% and a revenue growth 7.11% for BAX